Clinical Trial Update: Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for tesetaxel in chemotherapy-naive patients with progressive, castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• tesetaxel (tesetaxel)

Snippet

Sponsor: Genta Incorporated | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN